Tanke Biosciences Corp Operating Income Loss

Quick Answer

Tanke Biosciences Corp reported Operating Income Loss of $4.53 million for the year ending 2012.

  • Tanke Biosciences Corp showed an increase of +160.6% in Operating Income Loss from 2011 to 2012.
  • This data is from Tanke Biosciences Corp's annual report (Form 10-K), filed with the SEC on April 15, 2013.
  • XBRL data for this metric is available from 2010 to 2012 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 3 years of available data (2010 to 2012), Tanke Biosciences Corp's Operating Income Loss has grown by 3.6%.
  • Historical annual values: Fiscal year 2012: $4.53 million | Fiscal year 2011: $1.74 million | Fiscal year 2010: $4.37 million.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: